Ghent University Academic Bibliography

Advanced

Prilling as manufacturing technique for multiparticulate lipid/PEG fixed-dose combinations

Anouk Vervaeck, Tinne Monteyne, Lien Saerens UGent, Thomas De Beer UGent, Jean Paul Remon UGent and Chris Vervaet UGent (2014) EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 88(2). p.472-482
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
TRIAL, PELLETS, FORMULATIONS, METOPROLOL, THERAPY, HYPERTENSION, HYDROCHLOROTHIAZIDE, CONTROLLED-RELEASE, IN-VITRO DISSOLUTION, Immediate release, Controlled release, Prilling, Multiparticulate dosage forms, Fixed-dose combination, Polyethylene glycol, Fatty acids
journal title
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Eur. J. Pharm. Biopharm.
volume
88
issue
2
pages
472 - 482
Web of Science type
Article
Web of Science id
000345724400020
JCR category
PHARMACOLOGY & PHARMACY
JCR impact factor
3.85 (2014)
JCR rank
49/255 (2014)
JCR quartile
1 (2014)
ISSN
0939-6411
DOI
10.1016/j.ejpb.2014.06.018
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
5842499
handle
http://hdl.handle.net/1854/LU-5842499
date created
2015-02-09 14:19:03
date last changed
2017-03-22 15:16:49
@article{5842499,
  author       = {Vervaeck, Anouk and Monteyne, Tinne and Saerens, Lien and De Beer, Thomas and Remon, Jean Paul and Vervaet, Chris},
  issn         = {0939-6411},
  journal      = {EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS},
  keyword      = {TRIAL,PELLETS,FORMULATIONS,METOPROLOL,THERAPY,HYPERTENSION,HYDROCHLOROTHIAZIDE,CONTROLLED-RELEASE,IN-VITRO DISSOLUTION,Immediate release,Controlled release,Prilling,Multiparticulate dosage forms,Fixed-dose combination,Polyethylene glycol,Fatty acids},
  language     = {eng},
  number       = {2},
  pages        = {472--482},
  title        = {Prilling as manufacturing technique for multiparticulate lipid/PEG fixed-dose combinations},
  url          = {http://dx.doi.org/10.1016/j.ejpb.2014.06.018},
  volume       = {88},
  year         = {2014},
}

Chicago
Vervaeck, Anouk, Tinne Monteyne, Lien Saerens, Thomas De Beer, Jean Paul Remon, and Chris Vervaet. 2014. “Prilling as Manufacturing Technique for Multiparticulate lipid/PEG Fixed-dose Combinations.” European Journal of Pharmaceutics and Biopharmaceutics 88 (2): 472–482.
APA
Vervaeck, Anouk, Monteyne, T., Saerens, L., De Beer, T., Remon, J. P., & Vervaet, C. (2014). Prilling as manufacturing technique for multiparticulate lipid/PEG fixed-dose combinations. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 88(2), 472–482.
Vancouver
1.
Vervaeck A, Monteyne T, Saerens L, De Beer T, Remon JP, Vervaet C. Prilling as manufacturing technique for multiparticulate lipid/PEG fixed-dose combinations. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2014;88(2):472–82.
MLA
Vervaeck, Anouk, Tinne Monteyne, Lien Saerens, et al. “Prilling as Manufacturing Technique for Multiparticulate lipid/PEG Fixed-dose Combinations.” EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS 88.2 (2014): 472–482. Print.